Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that patients with ADHD have reliable access to prescriptions for essential medication.

The Department has made significant progress in improving the availability of medicines for attention deficit hyperactivity disorder (ADHD), working closely with industry and key stakeholders to overcome previous supply challenges. Through intensive collaboration with industry, NHS England and the Medicines and Healthcare products Regulatory Agency, supply issues have now been fully resolved. All ADHD medicines, across all formulations and strengths, are readily available for prescribing.

We continue to work closely with ADHD medicine suppliers to address any challenges promptly and to strengthen the resilience of the supply chain. This includes securing additional stock, expediting deliveries, and broadening the United Kingdom’s supplier base to meet future demand. To ensure a robust and sustainable supply, we are partnering with NHS England’s ADHD taskforce to develop growth forecasts and share them with industry, enabling effective planning and continuity of supply.